Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp

Bullboard Posts

Comment by OkanaganGuyon Mar 21, 2019 11:11am

141 Views

Post# 29516923

RE:Best in class

They are off on several of their numbers unfortunately. DYODD

Ravenus01 wrote: Somebody likes it:

First, MediPharm Labs has been generating massive revenues following the issuance of a Sales License from Health Canada in November 2018 and this a trend that has been gaining considerable traction. The Canadian cannabis oil company has been executing flawlessly and has sourced cannabis flower/trim from 15 different LPs and has signed three supply contracts, five contract processing agreements (all of which are 3+ years in duration), and four white label sales contracts, valued at over $85 million.
Based on the agreements that it has signed and the partners that it has in place, MediPharm Labs in a league of its own and we believe that the market undervalues its growth prospects. If you look at the section below, you will see the companies that MediPharm can be compared to and will see that it has a more attractive valuation and growth profile:

https://technical420.com/cannabis-article/4-cannabis-stocks-bright-futures-flying-under-radar